Whitehawk Therapeutics, Inc. · NASDAQ:WHWK
BEHZAD AGHAZADEH reported a 19.99% stake in Whitehawk Therapeutics, Inc. (Schedule 13D/A)
Event Feb 28, 2025 · Filed Mar 4, 2025
BEHZAD AGHAZADEH reported a 19.99% stake in Whitehawk Therapeutics, Inc., 11,914,961 shares, with active intent on Feb 28, 2025. Filed Mar 4, 2025 (Schedule 13D/A).
- Stake
- 19.99%
- Shares
- 11,914,961
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 18.00% | 9,515,802 |
| AVORO VENTURES LLC | 4.80% | 2,288,950 |
| BEHZAD AGHAZADEH | 19.99% | 11,914,961 |
Source
Related
- Whitehawk Therapeutics, Inc.
- Behzad Aghazadeh
- Whitehawk Therapeutics, Inc. shareholders
- Schedule 13D/A · Behzad Aghazadeh · Dec 23, 2024
- Schedule 13G/A · Fan Yu · Aug 14, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Form 4 · Dalal Anupam · Jul 30, 2026
- Form 4 · Dugan Margaret · May 18, 2026
- Form 4 · Ball Bryan · May 18, 2026